Latest Series C+ Funding Rounds
Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.
- Rounds
- 431 All time
- Disclosed funding
- $110B 388 disclosed amounts
- Median round
- $120M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| R Provides cloud infrastructure for AI-native software | $100M | Series CSeries C+ | Developer tools | United States | Investors | |
| L LassieCompany profile Offers prevention-focused pet insurance combined with daily care app and AI-driven claims processing Offers prevention-focused pet insurance combined with daily care app and AI-driven claims processing | $75M | Series CSeries C+ | Fintech | Sweden | Investors | |
| iC iSpace ChinaCompany profile iSpace China develops commercial launch vehicles and propulsion systems for satellite and constellation customers. iSpace China develops commercial launch vehicles and propulsion systems for satellite and constellation customers. | CN¥5B | Series D++Series C+ | Space tech | China | Investors | |
| T Provides in-network psychiatric care using AI-powered technology | $210M | Series DSeries C+ | Healthtech | United States | Investors | |
| G GitGuardianCompany profile Provides a non-human identity security platform to detect and remediate leaked secrets in code Provides a non-human identity security platform to detect and remediate leaked secrets in code | $50M | Series CSeries C+ | Cybersecurity | France | Investors | |
| L Loyal develops medicines intended to extend dogs’ lifespans. | $100M | Series CSeries C+ | Biotech | United States | Investors | |
| NS Nucleus SecurityCompany profile Provides unified vulnerability and exposure management for enterprises Provides unified vulnerability and exposure management for enterprises | $20M | Series CSeries C+ | Cybersecurity | United States | Investors | |
| NM Neurent MedicalCompany profile Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis. Neurent Medical develops NEUROMARK, a minimally invasive radiofrequency treatment for chronic rhinitis. | €62.5M | Series CSeries C+ | Healthtech | Ireland | Investors | |
| SH Solace Health connects patients with healthcare advocates. | $130M | Series CSeries C+ | Healthtech | United States | Investors | |
| OC Oxide Computer CompanyCompany profile Designs and manufactures integrated on-prem cloud computing systems Designs and manufactures integrated on-prem cloud computing systems | $200M | Series CSeries C+ | Hardware | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Andreessen Horowitz (a16z)
ASI, Labelbox, Valon
36rounds3led - 2Sequoia Capital
Whop, Blacksmith, Abby Care
32rounds3led - 3General Catalyst
Tractian, Legora, Modal Labs
29rounds0led - 4Lightspeed
Enveda, Snorkel AI, Profound
28rounds3led - 5Y Combinator (YC)
Tractian, Blacksmith, Jeeves
22rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.